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ABSTRAK
Kes keracunan plumbum (Pb) yang membimbangkan telah meningkat di beberapa 
negara tertentu. Semakin banyak bukti kajian menunjukkan pendedahan 
kronik terhadap plumbum memainkan peranan besar yang menyebabkan 
ketidakseimbangan prooksidan: antioksidan di dalam tisu otak dan perubahan 
histologi otak. Kajian ini dilakukan untuk mengenal pasti kesan agen antioksidan 
daripada kelapa sawit Malaysia, fraksi kaya tokotrienol (TRF) pada tisu otak tikus 
eksperimen berikutan keracunan plumbum. Lapan belas (n=18) tikus Sprague-
Dawley jantan, berusia 6 minggu, dibahagikan secara rawak kepada kumpulan 
kawalan (CTRL) dan kumpulan eksperimen; didedahkan kepada 0.2% w / v 
plumbum asetat, sebagai kumpulan PB2; dan yang didedahkan kepada 0.2% 
w / v plumbum asetat bersama pengambilan suplemen TRF (200 mg / kg berat 
badan) sebagai kumpulan PB2T. Eksperimen ini dijalankan selama 30 hari. Pada 
akhir kajian, tisu otak telah diambil dan perubahan histopatologi di kawasan 
hippocampus diperhatikan. Keputusan biokimia seperti aras plumbum, TRF dan 
malondialdehid (MDA) dalam tisu otak serta aras aktiviti superoksida dismutase 
(SOD) dalam eritrosit telah ditentukan. Terdapat neuron atipikal berciri apoptosis 
dan tidak teratur diperhatikan di kawasan hippocampus bagi kumpulan Pb2 yang 
didedahkan kepada plumbum berbanding kumpulan Pb2T. Parameter- parameter 
biokimia tisu otak menunjukkan penurunan aras plumbum yang siginifikan 
(p<0.05) di dalam kumpulan Pb2T berbanding Pb2. Walaupun tiada perbezaan 
yang signifikan diperolehi (p>0.05) bagi aras MDA, terdapat peningkatan yang 
signifikan (p<0.05) bagi aktiviti SOD eritrosit dalam PB2T berbanding PB2 dan 
CTRL. Pengambilan suplemen TRF dilihat dapat membaiki perubahan histopatologi 
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dalam tisu otak yang disebabkan oleh pendedahan plumbum melalui air minuman 
dengan mengurangkan pengumpulan plumbum dalam tisu otak tikus eksperimen.
Kata kunci: plumbum, neurotoksisiti, tekanan oksidatif, tokotrienol 
ABSTRACT
The occurrence of severe lead (Pb) poisoning has risen in certain countries. 
There is increasing evidence that chronic lead exposure disturbs the prooxidant: 
antioxidant balance in the brain tissue and alters brain histology. The present 
study observed the antioxidant effect of tocotrienol-rich fraction (TRF) on brain 
tissues of the experimental rats following lead poisoning. Eighteen (n=18) male 
Sprague-Dawley rats, 6-weeks old, were randomly divided into control (CTRL) 
group and experimental groups; fed with 0.2% w/v lead acetate, as PB2 group; 
and fed with 0.2% w/v lead acetate and daily TRF supplementation (200 mg/kg 
body weight) as PB2T group. The experiment was conducted for 30 days.  At the 
end of the study, the brain tissues were harvested and histopathological changes of 
the hippocampal region were observed. Biochemical findings such as brain lead, 
TRF and malondialdehyde (MDA) levels, and erythrocyte superoxide dismutase 
(SOD) activity were determined. It was observed that atypical apoptotic-like and 
disorganized neurons were present in the hippocampal region of the untreated 
PB2 group compared to PB2T group. Biochemical parameters showed a significant 
decrease (p < 0.05) in brain lead level in PB2T compared to PB. Even though no 
significant difference (p > 0.05) was obtained for MDA level, there was a significant 
increase (p < 0.05) in the erythrocyte SOD activity in PB2T compared to PB2 and 
CTRL. Supplementation with TRF improved histopathological changes in the brain 
tissues caused by lead exposure in drinking water by reducing lead accumulation 
in the brain of experimental rats. 
Keywords: lead, neurotoxicity, oxidative stress, rat, tocotrienol
INTRODUCTION
Lead (Pb) poisoning is one of the major 
public health concerns worldwide due 
to its adverse effects to the human 
body systems (Iyer et al.  2015). Lead 
poisoning can occur as a result of 
exposure to lead through air, household 
dust, sand, water and commercial 
productssuch as paint (Cao et al. 
2014). Risk factors of lead poisoning 
include the use of leaded gasoline, 
occupational exposure to heavy metals 
and battery recycling, water harvesting 
techniques using old pipes as well as 
the level of education among parents, 
guardian or child’s primary caregiver 
(Brown et al. 2005; Albalak et al. 2003). 
Lead poisoning in human is indicated 
when blood lead levels reach ≥≥ 10 μg/
dL whole blood (Taylor et al. 2013). The 
fatal dose is estimated at 500 mg of 
absorbed lead (Noji & Kelen 1989). The 
threshold for toxic effects of lead is yet 
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to be identified. However, blood lead 
levels of ≥≥ 80 μg/dL in children were 
reported to cause encephalopathy (Cao 
et al. 2014), whereas a lower blood 
lead level caused adverse effects on 
the central nervous system, though 
symptomless (Iyer et al. 2015).
 High blood lead levels were reported 
to affect physical development, 
auditory system, kidneys, bones and 
the most feared was the effect on the 
nervous system. Lead was reported to 
be highly neurotoxic and particularly 
affected the developing central 
nervous system (CNS) (Antonio-García 
& Massó-Gonzalez 2008). Previous 
studies of lead toxicity on the nervous 
system of mice found disruption in 
cognitive function due to changes in 
the cell morphology in certain regions 
of the brain (Huang & Schneider 2004; 
Yang et al.  2003).
 The present study hypothesized that 
lead-induced brain toxicity is highly 
attributable to oxidative stress. There 
is increase in evidence that chronic 
lead exposure plays an important 
role in the disruption of prooxidant: 
antioxidant balance in the brain tissue 
and alters brain histology which leads 
to physiological dysfunction (Bokara et 
al. 2008; Hamed et al. 2010). Oxidative 
stress occurs in the plasma and brain 
tissue in lead-exposed rats as evidenced 
by decreased important intracellular 
antioxidant enzymes and increased 
lipid peroxidation products (Xia et al. 
2010). To the best of our knowledge, 
past studies have observed the effect of 
lead consumption along with chelating 
agent or other supplementary elements. 
Other researchers have observed the 
histopathological changes in the lead 
exposed group (without treatment).
Our interest in the present study was 
to evaluate the brain histopathological 
and biochemical effects after the 
consumption of lead, along with 
chelating agent from Malaysian palm, 
tocotrienol-rich fraction (TRF) treatment.
TRF is a well known therapeutic agent 
as it possesses several medicinal 
properties including antioxidant, anti-
inflmmatory and effective free radical 
scavenging agent (Abd Aziz et al. 2012).
 Results obtained from the pilot 
experiment of the present study found 
that thirty days of lead ingestion even 
in a small dose of 0.2% v/w was 
capable of causing histopathological 
changes in the hippocampus region 
of rats (Abd Aziz et al. 2012). The 
present study was therefore aimed 
to determine the possible effects of 
TRF on rat brain exposed to 0.2% 
v/w lead. Determination of lead, TRF, 
superoxide dismutase (SOD) activity 
and malondialdehyde (MDA) levels 
as well as microscopic observation of 
brain tissue in the hippocampus were 
performed in order to better understand 
the involvement of oxidative stress as a 
mechanism of neurotoxicity oflead.
MATERIALS AND METHODS
ANIMALS
Ethical approval was obtained from the 
Universiti Kebangsaan Malaysia Animal 
Ethics Committee (UKMAEC), with 
approval number of PP/ANAT/2011/
FAIRUZ/19-MAY/377-MAY-2011-
MAY-2012 prior to the commencement 
of study. A total of eighteen male 
Sprague Dawley rats (6-weeks old, 
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weighing 150-200 gm) were obtained 
from the Laboratory Animal Resource 
Unit (LARU), Universiti Kebangsaan 
Malaysia. The rats were housed one 
animal per cage, acclimatized for one 
week, fed with commercial rat chow 
(Gold Coin, Malaysia) with distilled 
water ad libitum and maintained under 
controlled environment of 12 hrs light 
and dark cycle. 
EXPERIMENTAL DESIGN
Rats were randomly divided into three 
groups, with each group comprising of 
six animals (n=6). The groups were i) 
control group which received distilled 
water ii) group which received lead 
acetate (0.2% w/v) in drinking water, 
and iii) group which received lead 
acetate (0.2% w/v) in drinking water 
and daily force-fed with tocotrienol-rich 
fraction, TRF (Golden Hope Bioganic 
Sdn. Bhd., Malaysia) using oral gavage 
at 200 mg/kg body weight. TRF used 
in the study composed of 235.8 mg/g 
(31.16%) of γ-tocotrienol (GTT), 111.5 
mg/g (14.74%) of δδ-tocotrienol (DTT), 
208.5 mg/g (27.56%) of α-tocotrienol 
(ATT), 168.9 mg/g (22.33%) of αα-
tocoferol (ATF) and 31.8 mg/g (4.21%) 
of β-tocotrienol (BTT). In all groups, 
rats were maintained for thirty days 
and were sacrificed at the end of 
exposure. Histopathological study of 
the hippocampus was done using light 
microscope following hematoxylin and 
eosin (H&E) staining (Merck, Germany). 
In addition, another brain hemisphere 
were homogenized with ice-cold 
buffer (Tris-HCL, pH 7.5) (Sigma, United 
States of America) and centrifuged at 
10,000 x g at 4˚C for 10 mins. Brain 
lead levels were determined using 
atomic absorption spectroscopy (Perkin 
Elmer, United States of America), 
brain TRF levels by high-performance 
liquid chromatography (Shimadzu 
Corporation, Japan), erythrocyte 
superoxide dismutase (SOD) enzyme 
activity by antioxidant enzyme assay 
(Cayman, United States of America) and 
brain malondialdehyde (MDA) levels 
by lipid peroxidation product assay 
(Cayman, United States of America).
BRAIN HISTOLOGICAL STUDY
A hemisection of brain was analyzed 
for histopathological changes within the 
hippocampal subregions following lead 
exposure. Brain tissues were processed 
according to the standard protocol for 
light microscopy (Olympus, Japan). 
Tissues were fixed with 10% formalin 
(Ajax, Australia), dehydrated through 
graded alcohol series (25%-100%) 
(Hayman Ltd., England), cleared in 
toluene (Systerm Chemicals, Malaysia) 
and embedded in paraffin wax (Fisher 
Scientific, United States of America). 
Serial sections of 3 μm thickness 
were made using a microtome 
(Leica, Germany) and stained with 
H&E staining (Merck, Germany). 
Quantitative estimation of the number 
of apoptotic-like cells was done using 
an image analyzer (Leica, Germany) at 
x 20 objective based on a described 
method (Haynes et al. 2001).
ATOMIC ABSORPTION 
SPECTROSCOPY
The brain lead concentration was 
analyzed by atomic absorption 
spectrophotometer (Perkin-Elmer, 
United States of America) at 283.3 nm 
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based on a described method with 
slight modifications (Hamed et al. 2010). 
Brain hemisphere was weighed (1 gm) 
and placed into a polypropylene tube. 
Nitric acid, HNO3 (Merck, Germany) 
(1ml) was added to the brain tissue and 
digested in a shaking bath (Memmert, 
Germany) at 60˚C for 30 mins. 
Supernatant (100 µl) was then taken 
from the clear solution and diluted (1:5 
v/v) with deionized water. The standard 
curve was obtained by adding lead 
standard solutions (Fisher Scientific, 
United States of America) with increase 
in concentration corresponding to 20, 
40, 60, 80 and 100 µg/dL lead (Fisher 
Scientific, United States of America). 
Brain lead values were expressed as µg/
gm brain tissue.
HIGH-PERFORMANCE LIQUID 
CHROMATOGRAPHY
The brain TRF levels were analysed 
by reverse-phase high performance 
liquid chromatography with fluorescent 
detector of EX 294; EM 330 nm 
(Shimadzu Corporation, Japan). Brain 
homogenate (200 µl) were added to 
50 µl of butyllated hydroxytoluene 
(BHT, 10 mg/ml (Merck, Germany) in 
95% ethanol (Hayman Ltd., England). 
Another 1ml of 100% ethanol was 
then added to the sample and vortexed 
(Stuart, Germany). Samples were 
centrifuged (Jouan, France) at 5000 
rpm at 18˚C for 15 mins. Hexane (3 
ml) (Merck, Germany) was added to 
the supernatant and vortexed, before 
centrifuged again at 5000 rpm at 18˚C 
for 15 mins. The top layer (2.5 μl) was 
pipetted out (Eppendorf, France) into 
new tube and dried using vacuum 
concentrator (Heto Lab, Denmark). 
Dried samples were added with 
100µμl HPLC-grade hexane (Merck, 
Germany) and filtered using 1 cc/ml, 
0.2 μm syringe filter (Sartorius Stedim 
Biotech, Germany). Filtered samples 
(30 μl) was further diluted 1:10 with 
HPLC-grade hexane for analysis. The 
standard curve was obtained by adding 
TRF with increasing concentration 
corresponding to 2, 4, 6, 8, 10 and 14 
μg/ml TRF (Golden Hope Bioganic Sdn. 
Bhd., Malaysia). Brain TRF levels were 
expressed as μg/ml brain homogenate.
ANTIOXIDANT ENZYME ASSAY
The total cytosolic and mitochondrial 
superoxide dismutase (SOD) enzyme 
activities of erythrocytes in the blood 
were determined by Cayman Superoxide 
Dismutase Assay kit (Cayman, United 
States of America) based on described 
method (Kanematsu & Asada 1991). 
Haemolysates were obtained by 
centrifugation (Jouan, France) of fresh 
blood samples at 3000 rpm at 4˚C for 
10 mins, lysis of erythrocytes with ice-
cold distilled water at 1:4 v/v followed 
by centrifugation at 10000 x g at 4˚C for 
10 mins. Prior to analysis, supernatant 
(haemolysate) was diluted 1:100 (v/v) 
with sample buffer solution (50 mM 
Tris-HCL, pH 8.0) (Sigma, United States 
of America). Samples solution of 10 μl 
were added to microplate wells filled 
with 200 μl radical detector assay 
solution (tetrazolium salt in SOD assay 
buffer solution, 1:400)(Cayman, United 
States of America). Reaction was 
innitiated by the addition of 20 μl xantine 
oxidase solution (Cayman, United 
States of America) and the microplate 
was put on incubated plat shaker (New 
Brunswick Scientific, United Kingdom) 
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mins. Samples (150µμl) were used for 
each microplate well (Cayman, United 
States of America). The standard curve 
was obtained by adding MDA standard 
solutions (Cayman, United States of 
America) with increasing concentration 
corresponding to 0.625, 1.25, 2.5, 5.0, 
10.0, 25.0 and 50.0 μM MDA (Cayman, 
United States of America). Brain MDA 
levels were determined using ELISA 
reader (Biotech, United States of 
America) at 530-540 nm. Results were 
expressed as μM/ml brain homogenate.
STATISTICAL ANALYSIS
SPSS software version 19.0 (SPSS 
Incorporation, United States of America) 
was used in all analyses. ANOVA, with 
post-hoc Tukey HSD were performed 
to compare variables. All results were 
expressed as mean ± SD and P value 
<0.05 was accepted as statistically 
significant.
RESULTS
BRAIN HISTOLOGICAL STUDY
Effect of 30 days lead exposure 
with TRF supplementation on the 
hippocampus
A formal quantitative analysis by one-
way ANOVA demonstrated that lead 
caused an increase in the number of 
apoptotic-like cells in the hippocampal 
subregion scornusammonis CA1 (F= 
92.264, p<0.05) and cornusammonis 
CA3 (F= 78.704, p<0.05) (Table 1). 
Lead exposure was shown to cause 
histopathological changes in the 
hippocampus area cornusammonis 
CA1 (Figure 1) and area cornusammonis 
for 20 mins. The standard curve was 
obtained by adding SOD standard 
solutions (Cayman, United States of 
America) with increasing concentration 
corresponding to 0.025, 0.05, 0.1, 0.15, 
0.2 and 0.25 U/ml SOD (Cayman, 
United States of America). SOD 
activities were read using ELISA reader 
(Biotech, United States of America) 
at 440-460 nm. Erythrocytes SOD 
activities obtained through the SOD 
enzyme assay kit (Cayman, United 
States of America) were compared 
to the levels of haemoglobin (Hb) 
concentrations in each haemolysate 
sample using Cyanomethaemoglobin 
assay (Sigma, United States of America) 
based on a described method (Lewis & 
Shinton 1980). Results were expressed 
as U/mg Hb.
LIPID PEROXIDATION PRODUCT 
ASSAY 
The brain malondialdehyde (MDA) 
levels were determined by Cayman 
Malondialdehyde Assay kit (Cayman, 
United States of America) based on 
described method (Yagi 1998). Sodium 
dodecyl sulphate (SDS) solution (100 μl)
(Cayman, United States of America) were 
added to the brain homogenate (100 μl)
in a 5 ml tube and shaken thoroughly.
Colour reagent (thiobarbituric acid 
solution) (Cayman, United States of 
America) (4 ml) were added to the 
bottom of the tube. Tubes were capped 
and put vertically in the rack. After 
all tubes were brought to boil on a 
heated plate (Leica, Germany) for 1 hr, 
the chemical reaction was stopped by 
immediately putting the samples on ice 
for 10 mins. Samples were centrifuged 
(Jouan, France) at 1600 x g at 4˚C for 10 
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CA3 (Figure 2). Compared to the control 
(CTRL group), the group fed with 0.2% 
w/v lead acetate (PB2) showed neurons 
with apoptotic-like appearance with 
shrunken and condensed cytoplasm in 
addition to disorganized arrangement 
of neurons. TRF supplementation 
during lead exposure (PB2T group) 
was found to reduce the number of 
neuronal cells with apoptotic-like 
appearance at hippocampal subregion 
cornusammonis CA1 (Figure 1) and 
cornusammonis CA3 (Figure 2) when 
compared to PB2 group (P<0.05). 
However, disorganized arrangement 
of neurons was still markedly observed 
in PB2T group ascompared to CTRL 
group.
BIOCHEMICAL STUDY
Effect of 30 days lead exposure with 
TRF supplementation on brain lead 
level
Brain lead levels were found significantly 
higher in group receiving 0.2% w/v 
lead acetate, PB2 group (14.20 ± 1.01 
μg/gm) compared to CTRL group (5.36 
± 1.27 μg/gm) (p<0.05). Brain lead level 
in TRF-supplemented group during 
lead exposure (PB2T group) was found 
significantly lower (4.07 ± 0.78 μg/m) 
Table 1: Number of cells in the hippocampal subregionscornusammonis CA1 and CA3 with 
apoptotic-like morphology depending on the dose of lead exposure.* PB2 demonstrated significant 
increase of number of apoptotic-like cells compared to CTRL.
Figure 1: A) Photomicrograph of hippocampus CA1 stained with H&E (x100). B) Photomicrograph in 
higher magnification (x200). PB2 shows shrunken apoptotic neurons (darkly stained). PB2T shows 
reduced number of atypically morphology cells compared to PB2, but disorganized arrangement 
of cells compared to CTRL. Str. or.: stratum oriens, Str. rad.: stratum radiatum, Str. l-m: stratum 
lacunosum molecular, DG: dentate gyrus.
Group
 Hippocampal subregion
CA1  CA3
CTRL 3.50 ± 1.87  2.50 ± 1.64
PB2 23.67 ± 3.78* 25.67 ± 5.05*
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when compared to PB2 group (p<0.05) 
(Figure 3).
Effects of 30 days lead exposure 
with TRF supplementation on brain 
TRF level
Brain TRF levels were found significantly 
lower in group receiving 0.2% w/v lead 
acetate, PB2 group (0.24 ± 0.12 μg/
ml) compared to CTRL group (0.75 ± 
0.26 μg/ml) (p<0.05). Brain TRF level 
in TRF-supplemented group during 
lead exposure (PB2T group) was found 
significantly higher (0.68 ± 0.19 μg/ml) 
when compared to PB2 group (p<0.05) 
(Figure 4).
Effect of 30 days lead exposure with 
TRF supplementation on erythrocyte 
SOD activity.
No significant difference of erythrocyte 
SOD activity was found between groups 
Figure 2: A) Photomicrograph of hippocampus CA3 stained with H&E (x100). B) Photomicrograph in 
higher magnification (x400). Normal neuronal cells were observed in CTRL. B (i). PB2. B (ii) shows 
apoptotic neurons while PB2T. B (iii) shows reduced number of atypical cells. Disorganization of 
neuronal cells markedly observed in PB2 and PB2T.
Figure 3: Bar graph of brain lead level (μg/g 
brain). *PB2 shows significant difference of 
brain lead levels compared to PB2 and CTRL.
Figure 4: Bar graph of brain TRF level (μg/ml 
brain). *PB2 shows significant difference of 
brain TRF levels compared to PB2 and CTRL.
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receiving 0.2% w/v lead acetate, PB2 
group (192.31 ± 25.01 U/mgHb) and 
CTRL group (177.19 ± 42.26 U/mgHb) 
(p>0.05). Erythrocyte SOD activity in 
TRF-supplemented group during lead 
exposure (PB2T group) was found 
significantly higher (264.14 ± 36.32 U/
mgHb) when compared to PB2group 
and CTRLgroup (p<0.05) (Figure 5).
Effect of 30 days lead exposure with 
TRF supplementation on brain MDA 
level.
Brain MDA levels were found 
significantly higher in groups receiving 
0.2% w/v lead acetate, PB2 group 
(14.73 ± 2.96 μM) compared to CTRL 
group (9.16 ± 1.35 μM) (p<0.05). No 
significant difference in brain MDA 
level was found between groups 
receiving TRF supplementation during 
lead exposure, PB2T group (9.84 ± 2.99 
μM) when compared to PB2 group 
(14.73 ± 2.96 μM) (p>0.05) (Figure 6).
DISCUSSION
The exact mechanism of lead (Pb) 
inducing toxicity has been of great 
interest in view of its major toxic 
effects on the central nervous system. 
An earlier study proved that TRF 
inhibits glutamate-induced activation 
of phospholipase A2 and causes 
neuroprotection. TRF is also believed 
as metal chealing agent (Khanna et al. 
2010). A pilot study conducted prior to 
the present study concluded that thirty 
days lead ingestion even in a small 
dose of 0.2% w/v lead acetate through 
drinking water is capable of causing 
histopathological changes in the 
hippocampus of rats (Abd Aziz et al. 
2012). The present study was conducted 
to determine possible protective effect 
of antioxidant tocotrienol-rich fraction 
(TRF) during lead exposure in order 
to better understand the mechanism 
involved in lead-induced brain toxicity. 
The present study provides evidence of 
decreased antioxidant enzyme activity 
and increased lipid peroxidation product 
as indices of oxidative stress in rats 
exposed to lead. TRF supplementation 
was shown to produce beneficial 
effects by increasing erythrocytes 
superoxide dismutase (SOD) activity 
and reduce lead accumulation in the 
brain of experimental rats. Histological 
Figure 5: Bar graph of erythrocyte SOD activity 
(U/mghemoglobin). *PB2T shows significant 
difference of erythrocyte SOD activity 
compared to PB2 and CTRL.
Figure 6: Bar graph of brain MDA level (μM). 
*PB2 shows significant difference of brain MDA 
levels compared to CTRL.
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observation in the present study 
provides supportive evidence of 
decresed histopathological changes 
in the brain tissue following TRF 
supplementation during lead exposure.
 In relation to brain lead levels, results 
from the present study seemed to 
correlate with several studies reported 
to date. A similarly-designed study 
investigated the effect of green tea leaf 
extract (GTE) on animals treated with 
lead acetate 0.4% w/v for six weeks has 
reported significant decreased in brain 
and blood levels in the experimantal 
rats treated with antioxidant compared 
to non-treated group (Hamed et al. 
2010). Additionally, the study showed 
positive correlation between brain lead 
levels and lipid peroxides (LPO) and 
negative correlations with glutathione 
(GSH). As also observed in the present 
study, reduction of at least two-folds 
difference of brain lead levels might be 
due to the capability of TRF to act as 
an antioxidant agents to excrete lead 
from the brain tissue. Earlier researchers 
given twelve weeks supplement of 
antioxidant N-acetylcysteine (NAC) 
to lead-exposed workers, reported 
significant reduction in blood lead levels 
in the NAC treated group. Oxidative 
stress status was found lower in the 
treated group compared to the non-
treated group, due to the stimulated 
glutathione synthesis detected in the 
NAC-treated group (Kasperczyk et al. 
2013). Several previous studies have 
shown that NAC, an orally available 
precursor of cysteine, is a chelator 
of toxic elements and may stimulate 
glutathione synthesis, particularly in the 
presence of vitamins C and E (Kannan 
& Flora 2006; Blanusa et al. 2005).
 In relation to the effect of TRF 
supplementation on the degree of lead-
induced histopathological changes of 
brain tissue, the present study observed 
a significant decrease in number of 
cells with a typical morphology in TRF-
treated group compared to non-treated 
group, although there were disorganized 
arrangement of cells in both groups. 
This might be due to TRF, even in the 
presence of lead at concentration 
used, possibly capable still to maintain 
the oxidant: antioxidant balance. This 
condition prevents excessive reactive 
oxygen species (ROS) production 
thus protect cells’ lipid membrane, 
protein and nucleic acid. Histological 
observation however suggests that TRF 
consumption at the concentration used 
is capable of reducing lead-induced 
apoptotic-like cells but not sufficient 
to maintain organized arrangement of 
cells. Earlier researchers have reported 
the protective effect of antioxidant 
ascorbic acid on the histopathological 
alterations in the 21-day old male 
pups of female rats administered with 
antioxidant ascorbic acid (100 mg/kg/
day) during lead exposure (0.2% w/v) 
throughout pregnancy and lactation 
(Han et al. 2007). Increased risk 
of neuronal degeneration by lead-
induced apoptosis was observed in 
immature and developing nervous 
system based on over expression of pro-
apoptotic Bax gene, and antioxidant 
supplementation reported protective 
effects on pups’ hippocampal 
subregions cornusammonis CA1, 
cornusammonis CA3 and dentate 
gyrus in line with lowered levels of Bax 
protein and increased levels of Bcl-2 
when compared to the non-treated 
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group (Han et al. 2007). Additionally, 
a study on lead chloride (4 mM) 
interaction with selenium (Se) (60µgm/
kg body weight/day) reported marked 
reversing effect of both lead-induced 
alterations in neural cell adhesion 
molecules (NCAM), also concentration 
of lead in rat blood and hippocampus 
(Wang et al. 2013).
 The present study showed significant 
high levels of TRF in the brain of 
TRF-supplemented group close to 
the levels of the control group, when 
compared to the non-treated group.
TRF detected in the non-treated group 
therefore might have resulted from 
the amount of TRF that already exist 
in the rats’ body or obtained through 
diet given, however not sufficient to 
prevent the over production of free 
radicals which had lowered the brain 
TRF levels. Additionally, TRF levels in 
brain homogenate were also found to 
be negatively related to the brain lead 
levels. This is in accordance to a report 
by National Health and Nutrition 
Examination Survey III (NHANES III) 
on the possitive relationship between 
blood lead levels and oxidative stress 
markers in 10,098 adult subjects, 
in addition to negative correlations 
between blood lead levels and serum 
vitamin E, carotenoids and vitamin C 
(Lee et al. 2006). A study on the effect 
of vitamin E and vitamin C on lead 
exposure (500 mg/L) for 12 weeks 
to the liver and kidney of rats has 
reported a significant decrease of about 
thirty percents of initial TRF level, but 
not vitamin C when compared to the 
control group (Jurczuk et al. 2007). 
Beneficial effect of vitamin E (50 IU/
kg body weight) intraperitoneally 
administered during lead exposure (12 
mg/kg body weight) for 24 days has also 
been reported to prevent lead-induced 
testicular toxicity due to its antioxidant 
properties (Al-Masri 2015).
 The present study evaluated the effect 
of TRF supplementation on the indices 
of oxidative stress in order to better 
understand the mechanism involved 
in lead toxicity. SOD enzyme activity 
per mg haemoglobin was determined 
in haemolysates of erythrocytes 
instead of brain homogenates. This is 
because SOD is present much greater 
in erythrocytes than in most tissues. 
Futuremore, previous literatures have 
shown that lead is capable in reducing 
SOD activity and other reactive oxygen 
species in erythrocytes (Mousa et al. 
2002; Rendon-Ramirez et al. 2007). 
Erythrocyte SOD enzyme activitiy 
in TRF-treated group were found 
significantly higher compared to the 
control and non-treated group. This 
might be due to highly significant 
existing SOD enzymes in rats and in the 
presence of lead at the concentration 
used, able to neutralize excessive 
superoxide radicals produced by lead at 
the concentration used in the exposure. 
Besides, brain malondialdehyde (MDA) 
levels were also detected lower in 
the TRF-treated group compared to 
non-treated group. This might be 
due to TRF supplementation, at the 
concentration given, capable to protect 
cells’ lipid membrane from excessive 
superoxide radicals produced by 
lead, thus maintaining MDA levels 
similar to the control group. Effects of 
antioxidants like tocopherol, ascorbic 
acid and L-methionine following lead-
induced toxicity to the liver, kidney 
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and the brain of mice have shown that 
tocopherol (100 mg/kg body weight) 
significantly reduced lipid peroxidation 
products in both liver and brain tissues 
(Patra et al. 2001). A study on the effect 
of L-ascorbic acid and α-tocopherol on 
male rats exposed to lead has reported 
a decrease in nitric oxide and lipid 
peroxide levels to the normal level, 
in addition to a significant increase in 
SOD, glutathione peroxidase (GSHPx) 
and catalase (CAT) in both antioxidant-
treated groups (Das & Saha 2010). 
Indices of oxidative stress determined 
in the present study thus provide 
evidence of lead ability to produce 
oxidative stress in cells. 
CONCLUSION
The present study provided evidence 
of beneficial effect of tocotrienol-rich 
fraction (TRF) supplementation during 
lead exposure. TRF supplementation 
during lead exposure is capable of 
maintaining vitamin E at normal levels, 
reduces indices of oxidative stress, 
prevents histopathological alterations 
as well as reduces brain lead levels. 
Based on the limited parameters of 
antioxidant enzyme and product of 
lipid peroxidation determined in the 
present study, therefore further studies 
are needed to ascertain the exact 
action of lead in producing brain 
toxicity and other indices of oxidative 
stress following lead consumption.
 Due to limited duration of the study 
and limited technique used, a few 
histomorphometric analyses along with 
quantitative analysis on apoptosis or 
necrosis of the brain cells were unable 
to confirm the event of apoptosis in the 
present study. Future studies should 
confirm the event of apoptosis using 
specific apoptotic assay.
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